The company will look for treatments for tricky ailments, such as drug-resistant tuberculosis, Zika, hepatitis B and HIV.
A revolutionary treatment for cancer hits the U.S. market this year, but it can't be stockpiled.
A handful of very wealthy patrons are using unconventional tactics to get game-changing drugs to market faster.
Please log back in before proceeding.
There was an error logging in. Please try again.
Congrats! You are now logged in. Your exam is being submitted.
